John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$187M |
| 2 |
Walmart Inc
WMT
|
+$173M |
| 3 |
Dollar General
DG
|
+$171M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$164M |
| 5 |
Amazon
AMZN
|
+$162M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$243M |
| 2 |
Boeing
BA
|
+$202M |
| 3 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$187M |
| 4 |
Carnival Corporation Ltd
CCL
|
+$161M |
| 5 |
Philip Morris
PM
|
+$160M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 16.5% |
| 2 | Technology | 14.07% |
| 3 | Healthcare | 12.37% |
| 4 | Industrials | 9.06% |
| 5 | Financials | 7.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
K
1376
DELISTED
Kellanova
K
| $2.16M | 0.01% |
+40,106
| New | +$2.14M |
|
1377
PUT
Wynn Resorts
WYNN
$10.2B
| $2.16M | 0.01% |
+18,100
| New | +$2.16M |
|
1378
Gerdau
GGB
$8.5B
| $2.15M | 0.01% |
+699,521
| New | +$2.27M |
|
1379
OneSpan
OSPN
$575M
| $2.15M | 0.01% |
+111,940
| New | +$1.9M |
|
1380
Omega Healthcare
OHI
$14.1B
| $2.15M | 0.01% |
56,317
-1,283,298
| -96% | -$47.6M |
|
|
GTHX
1381
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $2.15M | 0.01% |
129,420
+53,563
| +71% | +$1.02M |
|
|
NPTN
1382
DELISTED
NEOPHOTONICS CORP
NPTN
| $2.14M | 0.01% |
340,877
+205,835
| +152% | +$1.44M |
|
1383
Verastem
VSTM
$621M
| $2.12M | 0.01% |
59,748
-43,183
| -42% | -$1.71M |
|
|
1384
PUT
AbbVie
ABBV
$467B
| $2.12M | 0.01% |
26,300
-108,700
| -81% | -$8.89M |
|
1385
SLR Investment Corp
SLRC
$693M
| $2.12M | 0.01% |
+101,664
| New | +$2.11M |
|
1386
CALL
Accenture
ACN
$114B
| $2.11M | 0.01% |
+12,000
| New | +$1.89M |
|
1387
Arcos Dorados Holdings
ARCO
$1.7B
| $2.11M | 0.01% |
302,576
+229,022
| +311% | +$1.86M |
|
1388
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$45.4B
| $2.11M | 0.01% |
23,000
+8,800
| +62% | +$793K |
|
1389
Eldorado Gold
EGO
$12.1B
| $2.11M | 0.01% |
455,380
+418,486
| +1,134% | +$1.63M |
|
|
CORE
1390
DELISTED
Core Mark Holding Co., Inc.
CORE
| $2.1M | 0.01% |
56,612
+7,526
| +15% | +$237K |
|
1391
PUT
Air Products & Chemicals
APD
$68.2B
| $2.1M | 0.01% |
11,000
+9,000
| +450% | +$1.55M |
|
|
ATRS
1392
DELISTED
Antares Pharma, Inc.
ATRS
| $2.1M | 0.01% |
691,293
+75,831
| +12% | +$246K |
|
1393
Maximus
MMS
$3.05B
| $2.08M | 0.01% |
+29,311
| New | +$2.06M |
|
1394
CALL
Deere & Co
DE
$175B
| $2.08M | 0.01% |
13,000
+10,000
| +333% | +$1.6M |
|
1395
CALL
3M
MMM
$92.3B
| $2.08M | 0.01% |
11,960
+2,392
| +25% | +$403K |
|
|
QTNT
1396
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $2.07M | 0.01% |
5,753
+4,089
| +246% | +$1.44M |
|
|
RETA
1397
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $2.06M | 0.01% |
+24,147
| New | +$2M |
|
1398
PUT
Five Below
FIVE
$14.5B
| $2.06M | 0.01% |
+16,600
| New | +$2.01M |
|
1399
FS KKR Capital
FSK
$3.33B
| $2.06M | 0.01% |
85,118
-28,759
| -25% | -$713K |
|
|
CALY
1400
Callaway Golf Company
CALY
$2.82B
| $2.06M | 0.01% |
128,971
-469,270
| -78% | -$7.72M |
|
Similar funds
John Overdeck's Q1 2019 Portfolio in Review
As of Q1 2019, John Overdeck held 3,708 positions worth $30.8B, up 21% from $25.5B the previous quarter. Its ten largest holdings account for 6.1% of the portfolio.
John Overdeck deployed $1.39B of net new capital in Q1 2019, opening 800 new positions and adding to 1,115 existing holdings. Its largest new stake was Dollar General: 1,470,962 shares worth $175M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Netflix, an estimated $243M trimmed.
- John Overdeck's largest Q1 2019 buy was Dollar General: 1,470,962 shares worth $175M.
- John Overdeck added most to AbbVie in Q1 2019, an estimated $187M increase.
- John Overdeck's biggest Q1 2019 reduction was Netflix, cutting an estimated $243M.
- John Overdeck fully exited Boeing in Q1 2019, selling an estimated $202M.
- John Overdeck's ten largest holdings make up 6.1% of its $30.8B portfolio in Q1 2019.
- John Overdeck opened 800 new positions and closed 741 in Q1 2019.
- John Overdeck's portfolio value rose 21% quarter-over-quarter to $30.8B.
Based on Two Sigma Investments's 13F filing for Q1 2019, filed 15 May 2019.